Search
Menu
Home
HTB
2009
October
02
HTB
2 October 2009
Contents
Antiretrovirals
Etravirine (Intelence) label change in the US due to severe hypersensitivity reactions
PK and drug interactions
Raltegravir trough levels reduced by etravirine may require use of TDM
Lopinavir/r affects PK exposure of some antimalarial drugs
Darunavir/r increases exposure to nevirapine
Interaction between Ginkgo biloba and efavirenz
Use of raltegravir in HIV-positive transplant recipients
Basic science and immunology
Trends in Immunology: free access issue on immune senescence
Low viral loads in elite controllers
Immune surveillance below the radar: study offers explanation for acyclovir’s failure to reduce HIV risk
Low-level HIV replication versus latency: identifying the source of viral rebounds during treatment interruption
BHIVA news
Detention and removal of HIV-positive people in the UK
Correspondence
Letter: comment on swine flu algorithm
On the web
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention abstracts
Access to HCV treatment in Eastern Europe
Guide to HIV and hepatitis B coinfection
TAG pipeline report
New TB website and resource
HIV and the kidneys
Video news: online resource
HTB RSS
Current issues
March 2024
February 2024
January 2024
Back issues
Special report
Modelling study challenges links between gender and PrEP: event-based dosing and easier daily dosing should work for all
12 February 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage